Elliott Brown
Identification of the molecular pathways involved in paediatric and adult acute myeloid leukaemia
Brown, Elliott
Authors
Contributors
Dr Barbara Guinn B.Guinn@hull.ac.uk
Supervisor
Dr Stefano Caserta S.Caserta@hull.ac.uk
Supervisor
Abstract
Acute myeloid leukaemia (AML) affects 3100 people every year in the UK, around 1% of whom are under 19 years of age. Despite improvements in immunotherapeutic treatment opportunities for AML, the rates of survival particularly in adults remain poor. We wanted to determine whether adult and paediatric AML, share common molecular pathways and therefore, the same therapies could be used to treat each.
Previous dataset analysis provided a group of differentially expressed genes in different risk subgroups of AML. Using a variety of analysis tools and a comprehensive literature review, the role of these antigens and microRNAs (miRs) were investigated in various diseases and specifically AML. Models were generated using miRs as biomarkers to predict prognosis grouping based on expression and qPCR was performed to evaluate their use as a biomarker in patient sera.
Nine leukaemia associated` antigens (LAAs) and four miRs were identified for further study due to their effects on patient prognosis. Investigation of the LAAs showed potential roles in cancerous drivers and leukaemogenesis, interacting with known important pathways. Following area under the curve analysis, mRNA-sequencing data from TCGA and TARGET demonstrated that combinations of miRs made powerful predictors of prognosis. qPCR showed no significant difference in expression levels of DEmiRs in sera samples.
BIRC5 may be a key target for specific subtypes of AML and the other LAAs have been found to interact with key pathways in other cancers. However, these often have little to no research in AML patients or cell lines. Furthermore, only miR-1915-5p showed promise as a serum biomarker, however, further investigation is needed following this study.
Citation
Brown, E. Identification of the molecular pathways involved in paediatric and adult acute myeloid leukaemia. (Thesis). University of Hull. https://hull-repository.worktribe.com/output/4224412
Thesis Type | Thesis |
---|---|
Deposit Date | Nov 16, 2022 |
Publicly Available Date | Feb 24, 2023 |
Keywords | Biomedical sciences |
Public URL | https://hull-repository.worktribe.com/output/4224412 |
Additional Information | Department of Biomedical Sciences, The University of Hull |
Award Date | Apr 1, 2022 |
Files
Thesis
(4.6 Mb)
PDF
Copyright Statement
© 2022 Brown, Elliott. All rights reserved. No part of this publication may be reproduced without the written permission of the copyright holder.
You might also like
Survivin’ acute myeloid leukaemia—a personalised target for inv(16) patients
(2021)
Journal Article
microRNA expression in acute myeloid leukaemia: New targets for therapy?
(2022)
Journal Article
Molecular Mechanisms and Therapies of Myeloid Leukaemia
(2022)
Journal Article
Downloadable Citations
About Repository@Hull
Administrator e-mail: repository@hull.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search